To the Editor:Primary aldosteronism,characterized by hypertension,with or without hypokalemia,is the most frequent form of endocrine hypertension,which is mostly caused by bilateral adrenal hyperplasia or aldosterone-...To the Editor:Primary aldosteronism,characterized by hypertension,with or without hypokalemia,is the most frequent form of endocrine hypertension,which is mostly caused by bilateral adrenal hyperplasia or aldosterone-producing adrenocortical adenomas(APAA).However,it can also be induced by aldosterone-producing adrenocortical carcinoma(APAC),which is rare.Because of the rarity and malignancy.展开更多
To the Editor:Non-alcoholic fatty liver disease(NAFLD)includes a spectrum of diseases:simple steatosis,nonalcoholic steatohepatitis(NASH),and the related fibrosis and cirrhosis.[1]The treatment of NAFLD should aim to ...To the Editor:Non-alcoholic fatty liver disease(NAFLD)includes a spectrum of diseases:simple steatosis,nonalcoholic steatohepatitis(NASH),and the related fibrosis and cirrhosis.[1]The treatment of NAFLD should aim to reverse or prevent liver fibrosis,which is associated with liver-specific morbidity or mortality,rather than just to reduce circulating liver enzyme activities and improve NASH.展开更多
基金1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University(No. ZYGD18017)
文摘To the Editor:Primary aldosteronism,characterized by hypertension,with or without hypokalemia,is the most frequent form of endocrine hypertension,which is mostly caused by bilateral adrenal hyperplasia or aldosterone-producing adrenocortical adenomas(APAA).However,it can also be induced by aldosterone-producing adrenocortical carcinoma(APAC),which is rare.Because of the rarity and malignancy.
基金supported by a grant from the 1.3.5 Project for Disciplines of Excellence,West China Hospital,Sichuan University(No.ZYGD 18017)
文摘To the Editor:Non-alcoholic fatty liver disease(NAFLD)includes a spectrum of diseases:simple steatosis,nonalcoholic steatohepatitis(NASH),and the related fibrosis and cirrhosis.[1]The treatment of NAFLD should aim to reverse or prevent liver fibrosis,which is associated with liver-specific morbidity or mortality,rather than just to reduce circulating liver enzyme activities and improve NASH.
